An FDA committee will meet next month to discuss lifting a ban on a number of peptides marketed for wellness. Compounding pharmacies have been gearing up for the moment.
June 25, 2026 10:11 AM EDT
Health Tech
Compounder Olympia Pharmaceuticals eyes peptide opportunity
Shelby Livingston
Health tech correspondent
FDA advisory panel voted to allow compounding pharmacies to make 6 of 7 peptides, despite safety/efficacy concerns, with…
An FDA advisory committee has recommended that three peptide drugs that were previously restricted because of potential safety…
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back…
As regulators weigh whether pharmacies can legally compound wellness peptides, companies are preparing for a repeat of the GLP-1…
This week, the FDA's Pharmacy Compounding Advisory Committee largely voted yes to allowing several peptides be produced by…
Ahead of an FDA advisory committee meeting to discuss lifting restrictions on seven popular peptides, agency reviewers have…
